Archive for the ‘japan retractions’ Category
Plagiarism and duplication can be deadly to a paper in any dose. In the case of a study on the toxicity of nanoparticles to plants, the publisher has presented the precise amount of plagiarism and duplications that ultimately felled the paper.
Specifically, according to Nanomaterials, 56% of “Potential Impact of Multi-Walled Carbon Nanotubes Exposure to the Seedling Stage of Selected Plant Species” was taken from other work.
Here are more details from the retraction notice, published last year:
We previously reported on three retractions — two by the Journal of Controlled Release (JCR) — of papers co-authored by Hossein Hosseinkhani, who is currently based at the National Taiwan University of Science and Technology in Taipei. Now, the JCR is pulling four more studies that list Hosseinkhani as a co-author.
A vociferous advocate for correcting the literature — who has been banned by two publishers for his persistent communications — has asked journals to retract one paper and correct three others for duplications.
After a reader flagged his 2004 paper on PubPeer last month, author Jaime Teixeira da Silva “immediately” contacted the journal to alert it that the paper had been duplicated, as he noted on a recent comment on our site:
We can’t keep up with the growing number of retraction notices, so we’ve compiled a list of recent duplications to update our records.
1. Authors don’t always intentionally duplicate their own work, of course. The first paper on our list was retracted after the authors included a figure from a previous paper by accident, according to the publisher: Read the rest of this entry »
A bone researcher in Japan has logged his sixth retraction, after acknowledging he duplicated substantial portions of a 2011 paper and added “honorary” co-authors.
The retraction, in Parkinsonism & Related Disorders, follows five others for Yoshihiro Sato, including one from JAMA, some of which were pulled over concerns regarding authorship and data integrity. The latest retraction duplicated text from another 2005 paper that was itself retracted last year, both for duplicating from this newly retracted paper and for “concerns about the underlying data.”
Sato — who is listed at Mitate Hospital on the paper — told the journal he takes full responsibility.
Yoshihiro Sato, listed at Mitate Hospital, is the only author of the paper who was not “honorary,” the managing editor of the journal confirmed. He and the same co-authors recently lost three other papers about preventing hip fractures for “concerns regarding data integrity” and authorship issues — one of those papers, published in JAMA, specified that Sato was responsible for the data. All four authors were also included in a retraction last year of a paper with “concerns about the underlying data;” there, too, Sato said his co-authors were named “for honorary reasons.”
Here’s the retraction notice for “Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: A randomized controlled trial,” published in Movement Disorders:
JAMA and another journal in its network have retracted three 2005 papers about preventing hip fractures, after an admission of scientific misconduct.
All papers are being retracted over concerns about data integrity, and “inappropriate assignment of authorship.” Four of the authors — all based in Japan — have co-authored all of the three newly retracted papers, and also share authorship of a previous retraction from 2015.
The JAMA paper was tagged with an Expression of Concern last year, regarding the “conduct, integrity, and scientific validity” of the paper.
Here’s the retraction notice for the JAMA paper, “Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke:” Read the rest of this entry »
Yes: “Mass analysis by Ar-GCIB-dynamic SIMS for organic materials” was mistakenly published a total of three times.
Over a year later, the journal pulled the two redundant publications. Here’s the retraction notice for one of them:
When journals discover duplicated material, many choose to retract — but a cancer journal recently faced with the same dilemma involving a researcher with multiple retractions under his belt has instead decided to flag the paper with an expression of concern.
An editor told us that Cancers considered retracting the paper, by gynecologic cancer researcher Noriyuki Takai, but decided not to because the paper
contains some novel content that is of interest to the scientific community.
“Epigenetic Therapy in Human Choriocarcinoma,” published in 2010, has been cited once, according to Thomson Reuters Web of Science, and self-plagiarizes from other publications by Takai and his co-author, Hisashi Narahara. Both are researchers at Oita University in Japan.
Here’s the expression of concern:
The most recent notice mentions the investigation, and specifies that the first author, Satoshi Hagiwara, was responsible for the problematic figures in the paper. Hagiwara is also the first author on two retracted papers we reported on last year; one of the earlier retractions also mentions the investigation, but does not assign responsibility to any particular author. All three papers share three authors.
The retraction notice for “Continuous Hemodiafiltration Therapy Ameliorates LPS-Induced Systemic Inflammation in a Rat Model,” published in the Journal of Surgical Research, explains the issues with the paper: